Tower Research Capital (TRC)’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.4K | Sell |
|
|||||
|
2025
Q2 | $31K | Buy |
|
|||||
|
2025
Q1 | $30.1K | Buy |
|
|||||
|
2024
Q4 | $11.2K | Buy |
|
|||||
|
2024
Q3 | $9.14K | Sell |
|
|||||
|
2024
Q2 | $47.7K | Buy |
|
|||||
|
2024
Q1 | $4.64K | Sell |
|
|||||
|
2023
Q4 | $9.41K | Buy |
|
|||||
|
2023
Q3 | $12.1K | Sell |
|
|||||
|
2023
Q2 | $13.5K | Sell |
|
|||||
|
2023
Q1 | $31K | Sell |
|
|||||
|
2022
Q4 | $51K | Sell |
|
|||||
|
2022
Q3 | $102K | Buy |
|
|||||
|
2022
Q2 | $60K | Sell |
|
|||||
|
2022
Q1 | $106K | Buy |
|
|||||
|
2021
Q4 | $41K | Sell |
|
|||||
|
2021
Q3 | $68K | Buy |
|
|||||
|
2021
Q2 | $49K | Sell |
|
|||||
|
2021
Q1 | $73K | Sell |
|
|||||
|
2020
Q4 | $147K | Sell |
|
|||||
|
2020
Q3 | $163K | Buy |
|
|||||
|
2020
Q2 | $10K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $29K | Buy |
|
|||||
|
2019
Q3 | $0 | Sell |
|
|||||
|
2019
Q2 | $7K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $34K | Buy |
|
|||||
|
2018
Q3 | $35K | Buy |
|
|||||
|
2018
Q2 | $1K | Sell |
|
|||||
|
2018
Q1 | $4K | Sell |
|
|||||
|
2017
Q4 | $34K | Buy |
|
|||||
|
2017
Q3 | $37K | Sell |
|
|||||
|
2017
Q2 | $50K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $9K | Buy |
|
|||||
|
2016
Q3 | $6K | Buy |
|